Legalize59765 laws
59765 laws
- § 1320b–23. Pharmacy benefit managers transparency requirements
- § 1320b–24. Consultation with Tribal Technical Advisory Group
- § 1320b–25. Reporting to law enforcement of crimes occurring in federally funded long-term care facilities
- § 1320b–26. Funding for providers relating to COVID–19
- § 1320b–3. Applicants or recipients under public assistance programs not to be required to make election respecting certain veterans’ benefits
- § 1320b–4. Nonprofit hospital or critical access hospital philanthropy
- § 1320c–1. Definition of quality improvement organization
- § 1320b–5. Authority to waive requirements during national emergencies
- § 1320b–6. Exclusion of representatives and health care providers convicted of violations from participation in social security programs
- § 1320b–7. Income and eligibility verification system
- § 1320b–8. Hospital protocols for organ procurement and standards for organ procurement agencies
- § 1320b–9. Improved access to, and delivery of, health care for Indians under subchapters XIX and XXI
- § 1320b–9a. Child health quality measures
- § 1320b–9b. Adult health quality measures
- § 1320c. Purpose
- § 1320c–10. Annual reports
- § 1320c–11. Exemptions for religious nonmedical health care institutions
- § 1320c–12. Medical officers in American Samoa, the Northern Mariana Islands, and the Trust Territory of the Pacific Islands to be included in the quality improvement program
- § 1320c–13. Repealed. [Pub. L. 103–432, title I, § 156(a)(1)](/us/pl/103/432/tI/s156/a/1), Oct. 31, 1994, [108 Stat. 4440](/us/stat/108/4440)
- §§ 1320c–14 to 1320c–19. Omitted
- § 1320c–2. Contracts with quality improvement organizations
- § 1320c–20. Repealed. [Pub. L. 97–35, title XXI, § 2113(k)](/us/pl/97/35/tXXI/s2113/k), Aug. 13, 1981, [95 Stat. 795](/us/stat/95/795)
- § 1320c–3. Functions of quality improvement organizations
- § 1320c–4. Right to hearing and judicial review
- § 1320d–4. Requirements
- § 1320c–5. Obligations of health care practitioners and providers of health care services; sanctions and penalties; hearings and review
- § 1320c–6. Limitation on liability
- § 1320c–7. Application of this part to certain State programs receiving Federal financial assistance
- § 1320c–8. Authorization for use of certain funds to administer provisions of this part
- § 1320c–9. Prohibition against disclosure of information
- § 1320d. Definitions
- § 1320d–1. General requirements for adoption of standards
- § 1320d–2. Standards for information transactions and data elements
- § 1320d–3. Timetables for adoption of standards
- § 1320d–5. General penalty for failure to comply with requirements and standards
- § 1320d–6. Wrongful disclosure of individually identifiable health information
- § 1320d–7. Effect on State law
- § 1320d–8. Processing payment transactions by financial institutions
- § 1320d–9. Application of HIPAA regulations to genetic information
- § 1320e. Comparative clinical effectiveness research
- § 1320e–1. Limitations on certain uses of comparative clinical effectiveness research
- § 1320e–2. Trust Fund transfers to Patient-Centered Outcomes Research Trust Fund
- § 1320e–3. Information exchange with payroll data providers
- § 1320f. Establishment of program
- § 14031. Transferred
- § 1320f–1. Selection of negotiation-eligible drugs as selected drugs
- § 1320f–2. Manufacturer agreements
- § 1320f–3. Negotiation and renegotiation process
- § 1320f–4. Publication of maximum fair prices
- § 1320f–5. Administrative duties and compliance monitoring